Medical research in Israel a wake up call for the government before the next crisis

Cite As:
Buchnik Tsipy, Klein Rinat, Getz Daphne. Medical research in Israel a wake up call for the government before the next crisis Haifa Israel: Samuel Neaman Institute, 2020. https://neaman.org.il/EN/Medical-research-in-Israel-a-wake-up-call-for-the-government-before-the-next-crisis

An analysis of CBS and OECD data on government investments in medical R&D reveals a gloomy picture: only 0.5% of government R&D investments are in the health care sector; the past five years have seen a 20% decline in hospital research funding

compared to other OECD countries, Israel is ranked lower in R&D health investments. In addition to this data, we also found that in Israel there is a lack of health program management and transparency, as well as a lack of health policy and long-term planning, which harms Israel's ability to deal with future crises.

Policymakers must learn from such models as are employed in countries comparable to Israel - countries that lead in the health R&D field, such as Finland, Norway, and Ireland.

It is imperative to establish a clear and long-term strategy that includes various scenarios (including those such as the "Covid-19"), to encourage collaborations between ministries and sectors, to invest in medical research at a rate similar to that of comparable countries, to enable access to Israeli health databases, with the required regulation, and to act with full transparency.

Publications that might interest you

Font Size:
Site Colors:
Accesskey
S - Skip navigation
1 - Home page
4 - Search
Accessibility Statement